Testing effectiveness (Phase 2)Ended earlyNCT01281956
What this trial is testing
PRX-00023 Therapy in Localization-Related Epilepsy
Who this might be right for
EpilepsyEpilepsy, Temporal LobePartial Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 12